AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

The Role of Big Data in Precision Medicine

Caris Life Sciences Celebrates 1,000+ Precision Medicine Studies, Advancing Cancer Research and Patient Outcomes

OncoHelix and Qualisure Diagnostics Partner to Bring Thyroid GuidePx® Test to Canadian Patients

Gates Foundation Invests $50 Million in Tessera Therapeutics to Advance Gene Therapy for Sickle Cell Disease

FDA Approves Ensartinib (Ensacove) as First-Line Treatment for ALK-Positive NSCLC

Guardant Health and Boehringer Ingelheim Collaborate to Advance Liquid Biopsy CDx for HER2-Targeted Therapy in NSCLC

Cartherics Receives $300K G-Rex Grant to Advance Cancer Cell Therapy Manufacturing

Roche Revolutionizes Mass Spectrometry Diagnostics with Launch of cobas® Mass Spec Solution

Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Sequencing Service Offerings

NeuroKaire Secures $10M to Transform Precision Medicine in Psychiatry and Neurology

Home
/
med-marvels
/
details

A New Hope: Odisha's First Successful CAR-T Cell Therapy Saves Young Life

NextEdge Admin

04 Oct 2024

2 min 18 sec

A 15-year-old girl named Trupti, suffering from blood cancer, received a new lease on life thanks to CAR-T cell therapy, successfully performed by a team at a prestigious hospital in Bhubaneswar. This marks the first successful CAR-T cell therapy for cancer treatment in Odisha and the fifth in India.

This groundbreaking therapy involves modifying a patient’s T-cells to target cancer cells more effectively. Trupti, who battled acute leukemia, became the first patient in eastern India to undergo this treatment. After undergoing chemotherapy, she received CAR-T cell therapy two days later. “My condition is normal now. There was a little fever, but I’m doing well. I’m grateful to all the doctors,” Trupti shared, filled with joy.

Dr. Priyanka Samal, Head of Clinical Hematology and Bone Marrow Transplant at IMS and SUM Hospital, highlighted that while CAR-T cell therapy is well-established in the West, it is still emerging in India. She reported that Trupti is thriving just a month after the procedure. The hospital's ability to provide this revolutionary treatment means patients no longer need to travel abroad and incur exorbitant costs.

Instead of spending crores, the therapy is available for approximately ₹30-35 lakh, a more affordable option in India. Trupti’s parents expressed their gratitude for their daughter's recovery, stating, “Every day is a blessing. We are just grateful to have our daughter back.” Trupti now dreams of becoming a doctor herself.